⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Candin for the Treatment of Common Warts

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Candin for the Treatment of Common Warts

Official Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Candin for the Treatment of Common Warts (Verruca Vulgaris) in Adolescents and Adults

Study ID: NCT05889845

Study Description

Brief Summary: The goal of this clinical trial is to compare outcome in healthy subjects 12 years of age and older with at least 3, but no more than 20, common warts (Verruca vulgaris) following treatment with Candin or placebo. The main questions it aims to answer are: * does treatment with Candin result in better clearance of warts than placebo * how many injections are required to result in wart clearance Participants will * have one wart selected for injection every two weeks until clearance * return 12 weeks after wart clearance for assessment of durability of response

Detailed Description: This study involves a comparison of an equal volume injection of Candin with an injection of placebo (unpreserved normal saline solution) in common warts. Subjects will be randomized 2:1 to receive Candin or placebo. During the Treatment Period, 1 dose (0.5 mL) of investigational product (IP) will be injected every 2 weeks into a single treatment wart until either clinical clearance of the treatment wart is achieved or a total of 10 injections have been administered. Subjects achieving clinical clearance of the treatment wart will receive a final injection at the site of the cleared wart and then immediately enter the Observational Period for 12 weeks. Complete resolution is achieved when a subject demonstrates clinical clearance for 12 weeks.

Eligibility

Minimum Age: 12 Years

Eligible Ages: CHILD, ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Cahaba Dermatology, Birmingham, Alabama, United States

Arkansas Pediatric Clinic, Bryant, Arkansas, United States

Johnson Dermatology, Fort Smith, Arkansas, United States

Dermatology Clinic of Arkansas, Hot Springs, Arkansas, United States

Velocity Clinical La Mesa, La Mesa, California, United States

Long Beach Research, Long Beach, California, United States

Integrative Skin Research, Sacramento, California, United States

Velocity Clinical Englewood, Englewood, Colorado, United States

Kaminska Dermatology, Chicago, Illinois, United States

Integrated Dermatology of Newton-Brighton, Brighton, Massachusetts, United States

Hamzavi Dermatology, Fort Gratiot, Michigan, United States

Schlessinger MD, Omaha, Nebraska, United States

Advocare Berlin Medical Associates, Berlin, New Jersey, United States

Bryn Mawr Health Center, Newtown Square, Pennsylvania, United States

Velocity Clinical Spartanburg, Spartanburg, South Carolina, United States

DermResearch, Austin, Texas, United States

Austin Institute for Clinical Research, Pflugerville, Texas, United States

Velocity Clinical Hampton, Hampton, Virginia, United States

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: